Classic Pharmaceuticals LLC is a manufacturer and distributor of over-the-counter (OTC), private-label pharmaceuticals to blue-chip drug (Walgreens, Rite Aid, and CVS) and retail (Kroger, Wal-Mart, and Dollar General) stores and distributors throughout the United States. The company's products are sold in more than 16,000 major drugstores nationwide, plus a wide range of independent pharmacies and other non-pharmacy locations.
Headquartered in Sherburne, New York, Classic currently manufactures two OTC private-label products — a nasal inhaler for the relief of cold and flu symptoms and a chocolated laxative. Both products are currently manufactured and packaged at the company's facility in New York.
"Aphena is pleased to make this strategic acquisition — of a small and growing private-label company — bringing us two very solid products and providing them to our current customer base as additional private-labeling opportunities," said Renard Jackson, President & CEO for Aphena. "Bringing new products such as these into the mix will enhance our private-label business, drive revenue and expand capabilities in our liquids and topicals division."
Aphena Pharma Solutions Inc. is an industry-leading organization providing turnkey contract packaging, repackaging and manufacturing solutions for the pharmaceutical, OTC, dietary supplements, animal health, health and beauty, consumer health and medical device markets.
Companies in this press-release
